90.89USD+0.44%Mkt Cap: 4.95B USDP/E: —Last update: 2026-06-01
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal ant…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap4.95B USD
Enterprise Value3.97B USD
Revenue (TTM)1.34M USD
Gross Profit1.34M USD
Net Income (TTM)-162.34M USD
Revenue/Share0.0320 USD
Last Price90.89 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-20.00
PEG—
EV/EBITDA-20.79
EV/Revenue2975.01
P/S3805.77
P/B4.23
EPS (TTM)-4.23
EPS (Forward)-4.65
52W Range
16.6493% of range96.50
52W High96.50 USD
52W Low16.64 USD
Profitability
Gross Margin100.00%
Oper. Margin-10050.32%
EBITDA Margin0.00%
Profit Margin-7973.33%
ROE-32.90%
ROA-30.58%
Growth
Revenue Growth-60.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-129.06M USD
CapEx (TTM)213.00K USD
FCF Margin-5316.59%
FCF Yield-1.43%
Net Debt-1.11B USD
Net Debt/EBITDA5.81
Balance Sheet
Debt/Equity0.00
Current Ratio29.25
Quick Ratio29.06
Book Value/Sh22.01 USD
Cash/Share20.33 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)125.83 USD
Target Range98.00 USD – 200.00 USD
# Analysts12
Ownership
Shares Out.54.67M
Float54.60M
Insiders0.13%
Institutions120.31%
Short Interest
Short Ratio13.5d
Short % Float13.54%
Short % Out.11.76%
Shares Short6.43M
Short (prev mo.)6.56M
Technical
SMA 5086.61 (+4.9%)
SMA 20052.96 (+71.6%)
Beta0.09
S&P 52W Chg27.94%
Avg Vol (30d)454.24K
Avg Vol (10d)519.89K
Technical Indicators
RSI (14)58.0
MACD0.8057
MACD Signal0.5812
MACD Hist.+0.2245
BB Upper91.63 USD
BB Middle87.46 USD
BB Lower83.29 USD
BB Width9.54%
ATR (14)4.486 USD
Vol Ratio (20d)1.02x